RZLT - Rezolute Inc
Rezolute Inc Logo

RZLT - Rezolute Inc

https://www.rezolutebio.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States. The company is headquartered in Redwood City, California.

52W High
$8.05
52W Low
$2.22
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.03
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.01
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
8.43
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
9.68%
Institutions (25–75% balanced)
90.03%
Shares Outstanding
86,996,000
Float
76,696,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-1.16
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.95%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.5781
Previous
0.6233
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025